Arkolith/Insider Trading/THRX/Form 4

Paster Anne-Mari

InsiderTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Oct 14, 2021
Net Buying
Open-Market Buys
$3.0M
Open-Market Sells
$0
Net Open-Market Flow
$3.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 12, 2021Buy(P)188K$16.00$3.0M711K
Oct 12, 2021Conversion(C)524K——524K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 12, 2021Conversion(C)693K——0

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-040245) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML